Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice

European Journal of Immunology

Volumn 37, Issue 12, 2007, Pages 3587-3596

  Tchorbanov, Andrey I ^a   Voynova, Elisaveta N ^a   Mihaylova, Nikolina M ^a   Todorov, Todor A ^b   Nikolova, Maria ^c   Yomtova, Vihra M ^d   Chiang, Bor Luen ^e   Vassilev, Tchavdar L ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b Medical School   (Bulgaria)

^c NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^d INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Autoreactive B cell; Fc IIb receptor; Systemic lupus erythematosus

Indexed keywords

ANTI DOUBLE STRANDED DNA ANTIBODY; CHIMERIC ANTIBODY; DIPHTHERIA TOXOID; DNA ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ALBUMINURIA; ALLOTYPE SUPPRESSION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL CULTURE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA PROTEIN COMPLEX; DRUG MECHANISM; DRUG TARGETING; FEMALE; GENE SILENCING; LUPUS ERYTHEMATOSUS NEPHRITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; CROSS-LINKING REAGENTS; DIPHTHERIA TOXOID; DISEASE MODELS, ANIMAL; DNA; FEMALE; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED MRL LPR; MOLECULAR MIMICRY; OLIGOPEPTIDES; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS;

EID: 37548998556     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737143     Document Type: Article

References (31)

1. Kotzin, B. L., Systemic lupus erythematosus. Cell 1996. 85: 303-306.
2. Chan, O. T., Hannum, L. G., Haberman, A. M., Madaio, M. P. and Shlomchik M. J., A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 1999. 189: 1639-1648.
3. Shlomchik M. J., Craft, J. E. and Mamula, M. J., From T to B and back again: Positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 2001. 1: 147-153.
4. Murakami, M., Yoshioka, H., Shirai, T., Tsubata, T. and Honjo, T., Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Intern. Immunol. 1995. 7. 877-882.
5. Edwards, J. C. W. and Cambridge, G., B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol. 2006. 6: 394-403.
6. Linnik, M., Staines, N. A., Berden, J. and Isenberg, D. A., Workshop report on some new ideas about the treatment of systemic lupus erythematosus. Lupus 2002. 11: 793-796.
7. Weide, R., Heymanns, J., Pandorf, A. and Koppler, H., Successful long-term treatment of systemic lupus erythematosus with rituximab maintenance therapy. Lupus 2004. 12: 779-782.
8. Alarcon-Segovia, D., Tumlin, J. A., Furie, R. A., McKay, J. D., Cardiel, M. H., Strand, V., Bagin, R. G. et al., LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: Results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2003. 48: 442-454.
9. Radic, M. Z. and Weigert, M., Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 1994. 12: 487-520.
10. Yachimovich-Cohen, N., Fischel, R., Bachar, N., Yarkoni, Y. and Eilat, D., Autoimmune NZB/NZW F1 mice utilize B cell receptor editing for generating high-affinity anti-dsDNA autoantibodies from low-affinity precursors. Eur. J. Immunol. 2003. 33: 2469-2478.
11. Voynova, E. N., Tchorbanov, A. I., Todorov, T. A. and Vassilev, T. L., Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes. Lupus 2005. 14: 543-550.
12. Daëron, M. and Lesourne, R., Negative signaling in Fc receptor complexes. Adv. Immunol. 2006. 89: 39-86.
13. Ravech, J. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 84-89.
14. Nimmerjahn, F. and Ravetch, J. V., Fcgamma receptors: Old friends and new family members. Immunity 2006. 24: 19-28.
15. Kaneko, Y., Nimmerjahn, F., Madaio, M. P. and Ravetch, J. V., Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 2006. 203: 789-797.
16. Takai, T., Ono, M., Hikida, M., Ohmori, H. and Ravetch, J. V., Augmented humoral and anaphylactic responses in Fcgamma RII-deficient mice. Nature 1996. 379: 346-349.
17. -/- mice. J. Exp. Med. 2002. 195: 1167-1174.
18. Mackay,, M., Stanevsky, A., Wang, T., Aranow, C., Li, M., Koenig, S., Ravetch, J. V. and Diamond, B., Selective dysregulation of the Fc gammaIIB receptor on memory B cells in SLE. J. Exp. Med. 2006. 203: 2157-2164.
19. Burny, W., Lebrun, P., Cosyns, J. P. and Saint-Remy, J. M., Treatment with dsDNA-anti-dsDNA antibody complexes extends survival, decreases anti-dsDNA antibody production and reduces severity of nephritis in MRLlpr mice. Lupus 1997. 6: 4-17.
20. Sun, Y., Fong, K.-Y., Chung, M. C. M. and Yoa, Z.-J., Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. Intern. Immunol. 2001. 13: 223-232.
21. Putterman, C., Deocharan, B. and Diamond, B., Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J. Immunol. 2000. 164: 2542-2549.
22. Deocharan, B., Qing, X, Lichauco, J. and Putterman, C., {Alpha}-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J. Immunol. 2002. 168: 3072-3078.
23. Weinrich, V., Sondermann, P. and Frey, J., Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms. Hybridoma 1996. 15: 109-116.
24. Samuelsson, A., Towers, T. L. and Ravetch, J. V., Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 2001. 291: 484-486.
25. Hoyer, B. F., Moser, K., Hauser, A. E., Peddinghaus, A., Voigt, C., Eilat, D., Radbruch, A. et al., Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J. Exp. Med. 2004. 199: 1577-1584.
26. Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A. and Harley, J. B., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003. 349: 1526-1533.
27. Pincus, S. H., Ju, S. T., Dorf, M. E., Ewing, L. P. and Araneo, B. A., Variable regions of antibodies to synthetic polypeptides. I. Characterization of an idiotope expressed on antibodies and T-cell factors. Mol. Immunol. 1985. 22: 445-461.
28. Mehod, A. R., Mant, C. T., Gera, L. and Stewart, J., Preparative reversed-phase liquid chromatography of peptides. Isocratic two-step elution system for high loads on analytical columns. J. Chromatogr. A 2002. 972: 87-99.
29. Bauminger, S. and Wilchek, M., The use of carbodiimides in the preparation of immunizing conjugates. Methods Enzymol 1980. 70: 151-159.
30. Shapira, M., Jibson, M., Muller, G. and Arnon, R., Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc. Natl. Acad. Sci. USA 1984. 81: 2461-2465.
31. + anti-DNA plasma cells. Nat. Immunol. 2005. 6: 99-106.